FRIDAY, Oct. 14, 2022 (HealthDay News) — New trial data shows that Pfizer’s updated COVID booster shot is more powerful against Omicron subvariants than the original shot, the company announced Thursday. The findings are reassuring, since human data on the tweaked vaccine was not available when the U.S. Food andContinue Reading
FRIDAY, Oct. 14, 2022 (HealthDay News) — A proposed ban on menthol cigarettes could have a significant impact on smoking rates, especially among minorities, new U.S. research suggests. Adult smokers who are younger, have mental health problems and are from racial/ethnic minority groups are more likely to use menthol cigarettesContinue Reading
THURSDAY, Oct. 13, 2022 (HealthDay News) — A new study is sounding the alarm about the addition of antihistamines to street forms of opioids — and how they might make a fatal overdose more likely. The prime drug in question is diphenhydramine, found commonly in over-the-counter allergy meds such asContinue Reading
THURSDAY, Oct. 13, 2022 (HealthDay News) — The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects. But Paxlovid can itself pose a risk for people taking widely prescribed heart medications to lower cholesterol, prevent blood clots or manageContinue Reading
THURSDAY, Oct. 13, 2022 (HealthDay News) — People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday. The Adderall and Adderall IR shortage is due to intermittent manufacturing delays at Teva, one ofContinue Reading
MONDAY, Oct. 10, 2022 (HealthDay News) — While politicians and health officials seek solutions to an opioid epidemic that kills tens of thousands every year, doctors who prescribe the pain medications are seeking alternatives for their patients. New research suggests one way to handle pain for minimally invasive knee orContinue Reading
MONDAY, Oct. 10, 2022 (HealthDay News) — At the height of the COVID-19 pandemic, more than 40% of Americans were untruthful about whether they had the virus or were ignoring safety precautions, a nationwide survey shows. The December survey of 1,700 people found 721 respondents had either misrepresented their COVIDContinue Reading
FRIDAY, Oct. 7, 2022 (HealthDay News) — Getting vaccinated and boosted greatly reduces the odds for hospitalization if you get infected with COVID-19, according to a large new study conducted at U.S. Veterans Health Administration facilities. “This is remarkable, good news about the power and effectiveness of receiving COVID-19 boostingContinue Reading
THURSDAY, Oct. 6, 2022 (HealthDay News) — Teen vaping continues at concerning levels, U.S. health officials reported Thursday. About 2.5 million middle school and high school students reported that they had vaped in the past 30 days in 2022, according to new data from the U.S. Centers for Disease ControlContinue Reading
THURSDAY, Oct. 6, 2022 (HealthDay News) — How many Americans will die of COVID-19 this winter could depend on how many get their booster shots, a new report shows. Up to 90,000 U.S. COVID deaths could be prevented through the fall and winter, but that is less likely if vaccineContinue Reading
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Australia is experiencing its worst flu season in five years, and that doesn’t bode well for the United States, federal health officials warned Tuesday. America’s flu season often mirrors what unfolds in Australia, where winter spans April through October. Making matters worse, onlyContinue Reading
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — A new study has found no evidence that COVID-19 shots increase the incidence of Guillain-Barré syndrome, according to researchers. “This is important because we can say that there is no significant increased risk of Guillain-Barré syndrome in the population,” said study first authorContinue Reading
TUESDAY, Oct. 4, 2022 (HealthDay News) — Almost 8 in 10 U.S. adults have received their primary COVID-19 vaccine series, but only 31% of children ages 5 to 11 have done the same, according to a new report based on late September figures from the U.S. Centers for Disease ControlContinue Reading
TUESDAY, Oct. 4, 2022 (HealthDay News) — While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cognitive, or mental, impairment in Black, Hispanic and Asian patientsContinue Reading